![]() |
|
|
Vol. 294, Issue 2, 571-579, August 2000
Department of Cell Biology and Neuroscience, Nelson Biological
Laboratories, Rutgers University, Piscataway, New Jersey
Systemic administration of selective serotonin reuptake inhibitors
(SSRIs) elicits larger increases in serotonin (5-HT) in raphe than in
forebrain sites. Because serotonergic neuronal activity is suppressed,
the mechanism underlying SSRI-induced increases in extracellular 5-HT
is unclear. This study determined whether local infusion of SSRIs also
elicited regionally selective increases in extracellular 5-HT, and
whether changes depended on serotonergic neuronal depolarization.
Conventional microdialysis methods were used to measure 5-HT in dorsal
raphe (DRN), median raphe, nucleus accumbens (NAcc), and frontal
cortex of unanesthetized rats. During infusion of SSRIs into
each site, the maximum response was an ~6- to 7-fold increase in 5-HT
in NAcc and frontal cortex, and an ~20-fold increase in DRN and
median raphe. The larger increase in 5-HT in raphe was confirmed using
zero-net-flux microdialysis. In NAcc, baseline 5-HT was 0.7 nM, and
levels increased to a maximum of 3.1 nM during infusion of the SSRI
citalopram. Baseline 5-HT in DRN was greater, 1.3 nM, and increased to
12.4 nM in response to citalopram. Consistent with evidence that
autoreceptor activation inhibits serotonergic neuronal discharge, SSRI
infusion into DRN produced a moderate decrease in 5-HT in NAcc.
However, increases in 5-HT in DRN elicited by SSRI infusion were
attenuated by 8-hydroxydipropylaminotetralin and tetrodotoxin. These
data indicate that depolarization-dependent 5-HT release was not fully
inhibited during SSRI infusion into DRN. In summary, SSRIs produce
larger increases in extracellular 5-HT in raphe than in forebrain
sites. Increases depend in part on depolarization-induced release,
which may be greater in raphe than in forebrain.
This article has been cited by other articles:
![]() |
P. Weikop, J. Kehr, and J. Scheel-Kruger Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors J Psychopharmacol, November 1, 2007; 21(8): 795 - 804. [Abstract] [PDF] |
||||
![]() |
L. E. O'Dell and L. H. Parsons Serotonin1B Receptors in the Ventral Tegmental Area Modulate Cocaine-Induced Increases in Nucleus Accumbens Dopamine Levels J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 711 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tao and S. B. Auerbach Opioid Receptor Subtypes Differentially Modulate Serotonin Efflux in the Rat Central Nervous System J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 549 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Celada, M. V. Puig, J. M. Casanovas, G. Guillazo, and F. Artigas Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors J. Neurosci., December 15, 2001; 21(24): 9917 - 9929. [Abstract] [Full Text] [PDF] |
||||